Cancer Epidemiologic Research in Understudied Populations Webinar Series
- Upcoming Topics and Speakers
- Past Topics and Speakers
- Related Links
- EGRP Planning Committee
The Epidemiology and Genomics Research Program hosts a quarterly webinar series, Cancer Epidemiologic Research in Understudied Populations. Understudied populations are groups about which there are limited data regarding cancer risks and outcomes that can inform cancer control policies and interventions. Examples of understudied populations include racial or ethnic groups; people subject to low socio-economic factors; non-metropolitan/rural populations; sexual and gender minorities; immigrant, migrant, or refugee populations; the incarcerated; and the elderly. The purpose of this webinar series is to highlight innovative cancer epidemiology research on these populations.
Presentation topics on understudied populations in cancer epidemiologic research may include:
- Cancer and health disparities
- Transdisciplinary approaches for cancer epidemiology in understudied populations
- Novel study designs and methodology
- Etiology including but not limited to biological and behavioral mechanisms, and environmental risk factors (social and physical)
- Implementation and intervention studies
Any interested individual is invited to participate; however, pre-registration is required. Each presentation will be about 30-40 minutes in length and allow for 30 minutes of discussion. Instructions for connecting to the webinars will be sent via e-mail to individuals who register.
For more information, please visit Think Tank on Understudied Populations in Cancer Epidemiologic Research: Implications for Future Needs.
Upcoming Topics and Speakers
There are currently no upcoming webinars scheduled.
Note: Additional speakers and topics may be added in the future.
Past Topics and Speakers
June 7, 2018 9:00 a.m. to 10:00 a.m. ET
Cancer-Related Risks Among People Who Are Opioid Dependent
Claire Vajdic, Ph.D.
Head of the Cancer Epidemiology Research Unit, Center for Big Data Research in Health, The University of New South Wales
Dr. Claire Vajdic is a cancer epidemiologist leading a program of research on the causes and consequences of cancer, and disparities in cancer care. Her vision is to use "big data" to support precision cancer prevention and cancer care. She uses traditional epidemiological study designs as well as integrated registry, survey, clinical, genomic, and routine administrative health data.
Dr. Vajdic uses her expertise in study design and data integration to successfully lead large-scale projects that have demonstrably improved clinical practice and public health policy through effective collaboration with clinicians, scientists, and consumers. For example, her research on the risk factors for ocular melanoma formed the basis of the decision by the International Agency for Research on Cancer (IARC) to classify sun exposure as having "limited evidence" of carcinogenesis on risk of ocular melanoma. Dr. Vajdic’s research comparing cancer risk in people with HIV and transplant recipients resulted in a paradigm shift in our understanding of the role of immune function in the prevention of a wide range of cancers (and is heavily cited in IARC monographs on infectious organisms). This data also supported the initiation of highly active anti-retroviral therapy at HIV diagnosis in current U.S. and Australian guidelines. Her research on the cancer incidence profile in kidney transplant recipients was influential in the development of the current global clinical practice guidelines, specifically those related to managing cancer risk.
In this webinar, Dr. Vajdic reviewed her research on the cancer profile of adults registered for opioid substitution therapy. She also discussed the methods and findings and highlighted the sparse data available for this high-risk group.
April 5, 2018 2:00 p.m. to 3:00 p.m. ET
Mass Incarceration and Cancer-Related Outcomes
Emily Wang, MD, MAS
Associate Professor, Yale School of Medicine
Co-founder, Transitions Clinic Network
Dr. Wang's research focuses on promoting health equity for vulnerable populations, especially individuals with a history of incarceration, through both prison and community based interventions. The Transitions Clinic Network, which she co-founded, is a consortium of 15 community health centers nationwide dedicated to caring for recently released prisoners and defining best practices for the health care of individuals leaving prison. Dr. Wang's presentation focused on cancer in incarcerated populations.
January 17, 2018 2:00 p.m. to 3:00 p.m. ET
Cancer Prevention and Control Research in Appalachian Kentucky
Robin Vanderpool, DrPH, CHES
Associate Professor, Department of Health Behavior & Society, University of Kentucky
Dr. Vanderpool's research interests include cancer health disparities among rural and Appalachian populations, HPV vaccination, dissemination and implementation research, the impact of cancer on employment and treatment outcomes, and cancer survivorship. Dr. Vanderpool discussed best practices and lessons learned from the Appalachian Center for Cancer Education, Screening, and Support (ACCESS) and the UK Rural Cancer Prevention Center (RCPC) projects.
October 18, 2017 1:00 p.m. to 2:00 p.m. ET
Cancer Health Disparities and Risk Factors in Homeless Populations
Travis P. Baggett, M.D., MPH
Clinician-Investigator, Division of General Medicine, Massachusetts General Hospital; Assistant Professor of Medicine, Harvard Medical School; and Staff Physician, Boston Health Care for the Homeless Program
Dr. Baggett's research focuses on the health of homeless people, with an emphasis on addictive behaviors and their medical consequences in this population. Dr. Baggett presented on cancer and cancer risk factors in homeless populations.
June 6, 2017 1:00 p.m. to 2:00 p.m. ET
Opportunities and Challenges in Survivorship Research in Adolescents and Young Adults
Scott Baker, M.D., M.S.
Director, Pediatric Blood and Marrow Transplantation and Survivorship Programs, Fred Hutchinson Cancer Research Center
Dr. Baker's research interests include short- and long-term effects of blood and marrow transplantation, incidence, risk factors and characteristics of cardiopulmonary, metabolic, renal, endocrine and reproductive late effects and quality-of-life outcomes in long-term cancer survivors. Dr. Baker presented on cancer in adolescents and young adults, especially highlighting cancer health disparities seen in outcomes and survivorship.
November 15, 2016
Lessons Learned from the NICHD/PCORI Transgender Cohort Study
Michael Goodman, M.D., M.P.H.
Associate Professor, Department of Epidemiology
Rollins School of Public Health, Emory University
Dr. Michael Goodman's current research focuses on quality of life treatment outcomes among prostate cancer patients, comparative effectiveness of colorectal cancer screening options, and health status of transgender people. Dr. Goodman shared lessons learned from a cohort study of mortality and morbidity in transgender persons, with a special emphasis on cancer-related issues in this population. This study, supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) and the Patient-Centered Outcomes Research Institute (PCORI), is potentially the largest cohort of transgender people available to date and the first study of its kind in the United States.
- Think Tank on Understudied Populations in Cancer Epidemiologic Research: Implications for Future Needs, September 2015
EGRP Planning Committee
- Tram Kim Lam, Ph.D., M.P.H., Program Director, Environmental Epidemiology Branch
- Damali N. Martin, Ph.D., M.P.H., Program Director, Genomic Epidemiology Branch
Questions about individual webinars or the series may be submitted via e-mail to the Planning Committee at NCIUnderstudiedPops@mail.nih.gov.